Logo image of VERX

VERTEX INC - CLASS A (VERX) Stock Fundamental Analysis

NASDAQ:VERX - Nasdaq - US92538J1060 - Common Stock - Currency: USD

25.21  -0.52 (-2.02%)

After market: 25.21 0 (0%)

Fundamental Rating

3

Taking everything into account, VERX scores 3 out of 10 in our fundamental rating. VERX was compared to 283 industry peers in the Software industry. Both the profitability and financial health of VERX have multiple concerns. VERX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

VERX had positive earnings in the past year.
In the past year VERX had a positive cash flow from operations.
In the past 5 years VERX always reported negative net income.
VERX had a positive operating cash flow in each of the past 5 years.
VERX Yearly Net Income VS EBIT VS OCF VS FCFVERX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

VERX's Return On Assets of -4.21% is in line compared to the rest of the industry. VERX outperforms 47.35% of its industry peers.
With a Return On Equity value of -20.32%, VERX perfoms like the industry average, outperforming 42.76% of the companies in the same industry.
Industry RankSector Rank
ROA -4.21%
ROE -20.32%
ROIC N/A
ROA(3y)-2.65%
ROA(5y)-4.32%
ROE(3y)-13.31%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
VERX Yearly ROA, ROE, ROICVERX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

VERX has a Gross Margin (65.00%) which is comparable to the rest of the industry.
VERX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for VERX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-0.54%
VERX Yearly Profit, Operating, Gross MarginsVERX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

VERX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VERX has been increased compared to 1 year ago.
VERX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, VERX has a worse debt to assets ratio.
VERX Yearly Shares OutstandingVERX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VERX Yearly Total Debt VS Total AssetsVERX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.10 indicates that VERX is not in any danger for bankruptcy at the moment.
VERX has a better Altman-Z score (3.10) than 60.42% of its industry peers.
VERX has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
VERX has a Debt to Equity ratio of 1.36. This is in the lower half of the industry: VERX underperforms 78.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Altman-Z 3.1
ROIC/WACCN/A
WACC11.23%
VERX Yearly LT Debt VS Equity VS FCFVERX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

VERX has a Current Ratio of 0.99. This is a bad value and indicates that VERX is not financially healthy enough and could expect problems in meeting its short term obligations.
VERX's Current ratio of 0.99 is on the low side compared to the rest of the industry. VERX is outperformed by 74.20% of its industry peers.
VERX has a Quick Ratio of 0.99. This is a bad value and indicates that VERX is not financially healthy enough and could expect problems in meeting its short term obligations.
VERX has a Quick ratio of 0.99. This is in the lower half of the industry: VERX underperforms 73.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
VERX Yearly Current Assets VS Current LiabilitesVERX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.09% over the past year.
VERX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.31% yearly.
VERX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.01%.
Measured over the past years, VERX shows a quite strong growth in Revenue. The Revenue has been growing by 15.71% on average per year.
EPS 1Y (TTM)15.09%
EPS 3Y25.31%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.01%
Revenue growth 3Y16.15%
Revenue growth 5Y15.71%
Sales Q2Q%14.56%

3.2 Future

VERX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.95% yearly.
Based on estimates for the next years, VERX will show a quite strong growth in Revenue. The Revenue will grow by 14.73% on average per year.
EPS Next Y5.87%
EPS Next 2Y14.97%
EPS Next 3Y24.47%
EPS Next 5Y20.95%
Revenue Next Year14.77%
Revenue Next 2Y14.7%
Revenue Next 3Y15.59%
Revenue Next 5Y14.73%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
VERX Yearly Revenue VS EstimatesVERX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
VERX Yearly EPS VS EstimatesVERX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 41.33, which means the current valuation is very expensive for VERX.
VERX's Price/Earnings ratio is in line with the industry average.
VERX is valuated expensively when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.
VERX is valuated quite expensively with a Price/Forward Earnings ratio of 31.27.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VERX indicates a somewhat cheap valuation: VERX is cheaper than 61.48% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of VERX to the average of the S&P500 Index (34.94), we can say VERX is valued inline with the index average.
Industry RankSector Rank
PE 41.33
Fwd PE 31.27
VERX Price Earnings VS Forward Price EarningsVERX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VERX is valued a bit cheaper than the industry average as 61.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 51.44
VERX Per share dataVERX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VERX's earnings are expected to grow with 24.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.04
PEG (5Y)N/A
EPS Next 2Y14.97%
EPS Next 3Y24.47%

0

5. Dividend

5.1 Amount

No dividends for VERX!.
Industry RankSector Rank
Dividend Yield N/A

VERTEX INC - CLASS A

NASDAQ:VERX (8/20/2025, 8:00:01 PM)

After market: 25.21 0 (0%)

25.21

-0.52 (-2.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners112.05%
Inst Owner Change16.43%
Ins Owners6.4%
Ins Owner Change28.08%
Market Cap4.00B
Analysts78.18
Price Target48.3 (91.59%)
Short Float %10.47%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.43%
Min EPS beat(2)3.56%
Max EPS beat(2)9.3%
EPS beat(4)4
Avg EPS beat(4)8.81%
Min EPS beat(4)3.56%
Max EPS beat(4)15.34%
EPS beat(8)8
Avg EPS beat(8)10.53%
EPS beat(12)11
Avg EPS beat(12)12.06%
EPS beat(16)15
Avg EPS beat(16)17.85%
Revenue beat(2)0
Avg Revenue beat(2)-1.95%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)-1.91%
Revenue beat(4)1
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)0.84%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)5
Avg Revenue beat(12)-0.07%
Revenue beat(16)8
Avg Revenue beat(16)0.16%
PT rev (1m)0.68%
PT rev (3m)1.93%
EPS NQ rev (1m)-5.7%
EPS NQ rev (3m)-14.87%
EPS NY rev (1m)0%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)-1.83%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 41.33
Fwd PE 31.27
P/S 5.62
P/FCF N/A
P/OCF 27.88
P/B 16.11
P/tB N/A
EV/EBITDA 51.44
EPS(TTM)0.61
EY2.42%
EPS(NY)0.81
Fwd EY3.2%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.9
OCFY3.59%
SpS4.48
BVpS1.57
TBVpS-1.17
PEG (NY)7.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.21%
ROE -20.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65%
FCFM N/A
ROA(3y)-2.65%
ROA(5y)-4.32%
ROE(3y)-13.31%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-0.54%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Debt/EBITDA 4.19
Cap/Depr 189.92%
Cap/Sales 23.28%
Interest Coverage N/A
Cash Conversion 178.54%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 3.1
F-Score4
WACC11.23%
ROIC/WACCN/A
Cap/Depr(3y)135.67%
Cap/Depr(5y)121.89%
Cap/Sales(3y)16.89%
Cap/Sales(5y)14.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.09%
EPS 3Y25.31%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y5.87%
EPS Next 2Y14.97%
EPS Next 3Y24.47%
EPS Next 5Y20.95%
Revenue 1Y (TTM)15.01%
Revenue growth 3Y16.15%
Revenue growth 5Y15.71%
Sales Q2Q%14.56%
Revenue Next Year14.77%
Revenue Next 2Y14.7%
Revenue Next 3Y15.59%
Revenue Next 5Y14.73%
EBIT growth 1Y-557.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.41%
EBIT Next 3Y28.57%
EBIT Next 5Y26.7%
FCF growth 1Y-140.27%
FCF growth 3Y-49.75%
FCF growth 5Y-35.88%
OCF growth 1Y112.79%
OCF growth 3Y21.47%
OCF growth 5Y12.25%